盐酸缬更昔洛韦片一盒多少钱？

The tablet is a systemic antiviral drug. Valganciclovir Hydrochloride Tablet is suitable for the treatment of patients with acquired immunodeficiency syndrome (AIDS) combined with cytomegalovirus (CMV) retinitis, and the prevention of CMV infection in high-risk solid organ transplant patients. Valganciclovir hydrochloride tablets are sensitive to human viruses including human cytomegalovirus (HCMV), and valganciclovir hydrochloride tablets are sensitive to herpes simplex virus-1 and herpes simplex virus-2 (HSV-1, HSV-2), human herpesvirus-6, 7, 8 (HHV-6, 7, 8), Epstein-Barr virus, varicella-zoster virus (VZV) and hepatitis B virus.

Valganciclovir Hydrochloride Tablets can inhibit viral activity mainly by inhibiting the synthesis of viral DNA: Valganciclovir Hydrochloride Tablets competitively inhibit viral DNA polymerase, preventing deoxyguanylate triphosphate from binding to DNA. The ganciclovir triphosphate in Valganciclovir Hydrochloride Tablets binds to viral DNA, terminating or limiting the elongation of the viral DNA chain. The IC50 of the antiviral effect of valganciclovir hydrochloride tablets on CMV in vitro ranges from 0.08μM (0.02ug/ml) to 14μM (3.5ug/ml).

How much does a box of valganciclovir hydrochloride tablets cost?

It is understood that valganciclovir hydrochloride is currently on the market in China. Since it is an imported original drug, it is subject to patent restrictions and is relatively expensive. The domestic valganciclovir hydrochloride specification is 450mg-60 tablets/box, and the price is approximately US$2,250.

Therefore, in order to reduce medical expenses, some patients choose to buy Roche's valganciclovir hydrochloride, which is available in India. The price is relatively cheap. India's valganciclovir hydrochloride tablets are 450mg*60 tablets/box, priced at about US$750. Due to the floating exchange rate, the price is not fixed. Please consult Medical Companion Travel for specific prices.

Adverse events (% of patients) were diarrhea (30%), tremor (28%), graft rejection (24%), nausea (23%), headache (22%), leg edema (21%), constipation (20%), back pain (20%), insomnia (20%), hypertension (18%), and vomiting (16%).